Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DEKM09
|
|||
| Drug Name |
GWP42006
|
|||
| Synonyms |
Cannabidivarin; Cannabidivarol; CBDV; 24274-48-4; CBD-V; UNII-I198VBV98I; I198VBV98I; Cannabidivarin (CBDV); 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-propylbenzene-1,3-diol; (1'R,2'R)-5'-methyl-2'-(prop-1-en-2-yl)-4-propyl-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol; cannabidivarine; (1R-trans)-2-(3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-propyl-1,3-benzenediol; SCHEMBL2759238; CHEMBL2387742; DTXSID801019159; ZINC5844413; BDBM50532215; AKOS030242161; DB14050; SB18950; 1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-propyl-, (1R-trans)-; C20217; Cannabidivarin (CBDV) 100 microg/mL in Methanol; Cannabidivarin (CBDV) 1000 microg/mL in Methanol
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Epilepsy [ICD-11: 8A60-8A68] | Phase 2 | [1] | |
| Company |
Greenwich Biosciences
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H26O2
|
|||
| Canonical SMILES |
CCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O
|
|||
| InChI |
1S/C19H26O2/c1-5-6-14-10-17(20)19(18(21)11-14)16-9-13(4)7-8-15(16)12(2)3/h9-11,15-16,20-21H,2,5-8H2,1,3-4H3/t15-,16+/m0/s1
|
|||
| InChIKey |
REOZWEGFPHTFEI-JKSUJKDBSA-N
|
|||
| CAS Number |
CAS 24274-48-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02365610) A Study of GWP42006 in People With Focal Seizures - Part B. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.